Maxwell Biosciences, Inc. News Releases

Maxwell Biosciences Subsidiary Havih Announces Partnership with the Government of Andhra Pradesh

Thu, 18 Dec 2025 09:00:00 -0500

This partnership will establish a new research and production facility in Andhra Pradesh, driving India's transition toward pharmaceutical leadership and creating high-tech jobs Austin, Texas--(Newsfile Corp. - December 18, 2025) - Maxwell Biosciences subsidiary, Havih Envirosciences, an Indian citizen-owned and operated life sciences company, announced a strategic partnership with the Government of Andhra Pradesh to establish advanced pharmaceutical research and production capabilities in the...

Havih, a Maxwell Biosciences Subsidiary, Announces Partnership with the Government of Andhra Pradesh

Wed, 17 Dec 2025 22:30:00 -0500

This partnership will establish a new research and production facility in Andhra Pradesh, driving India's transition toward pharmaceutical leadership and creating high-tech jobs Pulivendula, Andhra Pradesh, India--(Newsfile Corp. - December 17, 2025) - Havih Envirosciences, an Indian citizen-owned and operated life sciences company and subsidiary of Maxwell Biosciences, announced a strategic partnership with the Government of Andhra Pradesh to establish advanced pharmaceutical research and...

Former US Congressman Dr. Brad Wenstrup Joins Maxwell Board

Thu, 20 Nov 2025 09:00:00 -0500

Dr. Brad Wenstrup has broad experience in government, military and civilian medicine and expertise in managing bacterial, fungal and viral infections, key to Maxwell's vision to create health for the world Austin, Texas--(Newsfile Corp. - November 20, 2025) - Maxwell Biosciences ("Maxwell"), a preclinical drug platform company developing a synthetic immune system that may serve as a key biodefense asset, today announced the appointment of Dr. Brad Wenstrup to its Board of Directors. This...

Maxwell Biosciences Marks Scientist Appreciation Day With Renewed Call to Recognize Scientists

Mon, 18 Aug 2025 09:00:00 -0400

Company holiday celebrates scientific impact and invites underrecognized researchers to connect Austin, Texas--(Newsfile Corp. - August 18, 2025) - Maxwell Biosciences, a global health technology company pioneering a new category of immune-inspired small molecules called Claromers™, today celebrates Scientist Appreciation Day, an official company holiday that honors the essential contributions of scientists. The observance is a call to give scientists greater visibility and broader recognition...

Maxwell Biosciences Announces Closing of $20M Financing Round

Thu, 07 Aug 2025 09:30:00 -0400

Investment accelerates Maxwell's path toward FDA trials and global market readiness Austin, Texas--(Newsfile Corp. - August 7, 2025) - Maxwell Biosciences, a global health technology company pioneering a new category of immune-inspired small molecules called Claromers™, today announced the closing of its $20 million financing round. The funds will support Maxwell's upcoming FDA clinical trials and advance AI-driven R&D. The funds will also expand commercialization in multiple other industries in...

Maxwell Biosciences Announces AI Department & Hiring of Jon McClure

Thu, 17 Jul 2025 09:00:00 -0400

New leadership to spearhead AI-driven breakthroughs in drug discovery and operational excellence Austin, Texas--(Newsfile Corp. - July 17, 2025) - Maxwell Biosciences ("Maxwell"), a global health technology company pioneering immune-inspired small molecules called Claromers™, today announced new engineering leadership for its Artificial Intelligence efforts—further cementing its decade-long commitment to AI-first innovation. As part of this initiative, the company has appointed Jon McClure as...

Maxwell Targets $500B Cosmetics Market with Microbiome-Friendly Antiseptics

Wed, 11 Jun 2025 12:00:00 -0400

Austin, Texas--(Newsfile Corp. - June 11, 2025) - Maxwell Biosciences, an innovator in technology that behaves like the natural immune system, announces its strategic entry into partnerships and licensing deals in the cosmetics and personal care market with its immune-inspired Claromer™ platform. The company's breakthrough Claromer™ technology is now being tested by some of the top cosmetics companies in the world. Maxwell aims to usher in a new generation of personal care products designed for...

Maxwell Biosciences Secures Anti-Diarrheal US Military Agreement

Wed, 23 Apr 2025 09:00:00 -0400

Maxwell's 7th signed US military agreement is for in vitro testing of Maxwell's Claromers for the treatment of diarrheal pathogens Austin, Texas--(Newsfile Corp. - April 23, 2025) - Maxwell Biosciences, a preclinical drug platform company that develops ClaromersTM, synthetic small molecules that mimic and improve upon the natural immune system, today announced a new collaboration. Maxwell has entered into a Limited Purpose Cooperative Research and Development Agreement (LP-CRADA) with the U.S....

Maxwell Biosciences Secures US Military Agreement to Research Scientific Aspects of Claromer Technology

Wed, 05 Mar 2025 09:00:00 -0500

U.S. Army Institute of Surgical Research to conduct key studies intended to further our knowledge of the effects of Claromer technology Austin, Texas--(Newsfile Corp. - March 5, 2025) - Maxwell Biosciences, a preclinical drug platform company that develops ClaromersTM, synthetic small molecules that mimic and improve upon the natural immune system, today announced a new collaboration. Maxwell has entered into a Cooperative Research and Development Agreement with the U.S. Army Institute of...

Maxwell Biosciences Secures US Military Research Agreement to Combat Dengue Fever

Wed, 26 Feb 2025 09:00:00 -0500

U.S. Naval Infectious Diseases Diagnostic Laboratory to study dengue fever activity of Claromer antiviral compounds, combatting a rapidly growing mosquito-borne viral infection and a national priority biodefense threat Austin, Texas--(Newsfile Corp. - February 26, 2025) - Maxwell Biosciences, a preclinical drug platform company that develops ClaromersTM, synthetic small molecules that mimic and improve upon the compounds of the human immune system, today announced a new collaboration. Maxwell...